Privia Health Group, Inc. (PRVA)

$17.59

+0.24

(+1.38%)▲

Market is closed - opens 7 PM, 07 Oct 2024

Performance

  • $17.40
    $17.68
    $17.59
    downward going graph

    1.08%

    Downside

    Day's Volatility :1.58%

    Upside

    0.51%

    downward going graph
  • $15.92
    $24.35
    $17.59
    downward going graph

    9.49%

    Downside

    52 Weeks Volatility :34.62%

    Upside

    27.76%

    downward going graph

Returns

PeriodPrivia Health Group, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
1.58%
5.7%
0.0%
6 Months
-5.6%
6.7%
0.0%
1 Year
-22.99%
18.4%
0.0%
3 Years
-20.23%
20.8%
-20.2%

Highlights

Market Capitalization
2.1B
Book Value
$4.98
Earnings Per Share (EPS)
0.12
PE Ratio
147.67
Wall Street Target Price
25.61
Profit Margin
0.88%
Operating Margin TTM
1.21%
Return On Assets TTM
0.8%
Return On Equity TTM
2.63%
Revenue TTM
1.7B
Revenue Per Share TTM
14.32
Quarterly Revenue Growth YOY
2.1999999999999997%
Gross Profit TTM
134.8M
EBITDA
20.0M
Diluted Eps TTM
0.12
Quarterly Earnings Growth YOY
-0.52
EPS Estimate Current Year
0.15
EPS Estimate Next Year
0.24
EPS Estimate Current Quarter
0.05
EPS Estimate Next Quarter
0.06

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 26 Wall street analysts offering stock ratings for Privia Health Group, Inc.(by analysts ranked 0 to 5 stars)
Based on 26 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
23
22
23
Hold
3
3
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 45.59%

Current $17.59
Target $25.61

Company Financials

FY18Y/Y Change
Revenue
657.6M
-
Net Income
-3.0M
-
Net Profit Margin
-0.46%
-
FY19Y/Y Change
Revenue
786.4M
↑ 19.58%
Net Income
8.2M
↓ 370.83%
Net Profit Margin
1.05%
↑ 1.51%
FY20Y/Y Change
Revenue
817.1M
↑ 3.91%
Net Income
31.2M
↑ 278.99%
Net Profit Margin
3.82%
↑ 2.77%
FY21Y/Y Change
Revenue
966.2M
↑ 18.25%
Net Income
-190.6M
↓ 710.19%
Net Profit Margin
-19.73%
↓ 23.55%
FY22Y/Y Change
Revenue
1.4B
↑ 40.41%
Net Income
-12.1M
↓ 93.67%
Net Profit Margin
-0.89%
↑ 18.84%
FY23Y/Y Change
Revenue
1.7B
↑ 22.19%
Net Income
23.1M
↓ 291.3%
Net Profit Margin
1.39%
↑ 2.28%
Q1 FY23Q/Q Change
Revenue
386.3M
↑ 6.0%
Net Income
7.3M
↓ 58.8%
Net Profit Margin
1.9%
↓ 2.98%
Q2 FY23Q/Q Change
Revenue
413.4M
↑ 7.01%
Net Income
7.3M
↓ 0.68%
Net Profit Margin
1.76%
↓ 0.14%
Q3 FY23Q/Q Change
Revenue
417.3M
↑ 0.95%
Net Income
5.6M
↓ 22.42%
Net Profit Margin
1.35%
↓ 0.41%
Q4 FY23Q/Q Change
Revenue
440.8M
↑ 5.64%
Net Income
2.8M
↓ 49.71%
Net Profit Margin
0.64%
↓ 0.71%
Q1 FY24Q/Q Change
Revenue
415.2M
↓ 5.8%
Net Income
3.0M
↑ 5.14%
Net Profit Margin
0.72%
↑ 0.08%
Q2 FY24Q/Q Change
Revenue
422.3M
↑ 1.71%
Net Income
3.5M
↑ 16.19%
Net Profit Margin
0.82%
↑ 0.1%
FY19Y/Y Change
Total Assets
270.2M
-
Total Liabilities
162.7M
-
FY20Y/Y Change
Total Assets
329.0M
↑ 21.75%
Total Liabilities
185.3M
↑ 13.87%
FY21Y/Y Change
Total Assets
686.4M
↑ 108.64%
Total Liabilities
236.2M
↑ 27.45%
FY22Y/Y Change
Total Assets
792.8M
↑ 15.51%
Total Liabilities
273.8M
↑ 15.91%
FY23Y/Y Change
Total Assets
999.9M
↑ 26.12%
Total Liabilities
392.5M
↑ 43.38%
Q1 FY23Q/Q Change
Total Assets
875.3M
↑ 10.41%
Total Liabilities
318.8M
↑ 16.46%
Q2 FY23Q/Q Change
Total Assets
937.6M
↑ 7.11%
Total Liabilities
366.3M
↑ 14.88%
Q3 FY23Q/Q Change
Total Assets
992.3M
↑ 5.84%
Total Liabilities
401.3M
↑ 9.56%
Q4 FY23Q/Q Change
Total Assets
999.9M
↑ 0.76%
Total Liabilities
392.5M
↓ 2.18%
Q1 FY24Q/Q Change
Total Assets
1.0B
↑ 3.17%
Total Liabilities
408.8M
↑ 4.14%
Q2 FY24Q/Q Change
Total Assets
1.1B
↑ 4.46%
Total Liabilities
434.0M
↑ 6.18%
FY18Y/Y Change
Operating Cash Flow
5.2M
-
Investing Cash Flow
-165.0K
-
Financing Cash Flow
15.4M
-
FY19Y/Y Change
Operating Cash Flow
24.4M
↑ 364.05%
Investing Cash Flow
-5.7M
↑ 3360.0%
Financing Cash Flow
-10.9M
↓ 170.77%
FY20Y/Y Change
Operating Cash Flow
38.9M
↑ 59.66%
Investing Cash Flow
-380.0K
↓ 93.34%
Financing Cash Flow
-767.0K
↓ 92.94%
FY21Y/Y Change
Operating Cash Flow
55.1M
↑ 41.57%
Investing Cash Flow
-32.8M
↑ 8525.0%
Financing Cash Flow
213.7M
↓ 27956.71%
FY22Y/Y Change
Operating Cash Flow
47.2M
↓ 14.28%
Investing Cash Flow
-104.0K
↓ 99.68%
Financing Cash Flow
-19.7M
↓ 109.21%
Q1 FY23Q/Q Change
Operating Cash Flow
-13.4M
↓ 145.91%
Investing Cash Flow
-24.9M
↑ 165606.67%
Financing Cash Flow
1.5M
↓ 24.53%
Q2 FY23Q/Q Change
Operating Cash Flow
7.6M
↓ 156.84%
Investing Cash Flow
-72.0K
↓ 99.71%
Financing Cash Flow
-819.0K
↓ 155.45%

Technicals Summary

Sell

Neutral

Buy

Privia Health Group, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Privia Health Group, Inc.
Privia Health Group, Inc.
-8.06%
-5.6%
-22.99%
-20.23%
-50.07%
Solventum Corp
Solventum Corp
3.3%
0.39%
-2.66%
-2.66%
-2.66%
Doximity, Inc.
Doximity, Inc.
19.91%
69.41%
104.19%
-42.18%
-18.17%
Veeva Systems Inc.
Veeva Systems Inc.
-5.67%
-4.75%
2.02%
-26.84%
32.81%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
2.66%
2.18%
32.41%
48.59%
48.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Privia Health Group, Inc.
Privia Health Group, Inc.
147.67
147.67
NA
0.15
0.03
0.01
NA
4.98
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Doximity, Inc.
Doximity, Inc.
54.36
54.36
2.42
0.9
0.17
0.11
NA
4.92
Veeva Systems Inc.
Veeva Systems Inc.
54.69
54.69
1.18
4.76
0.13
0.06
NA
32.04
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
26.31
26.31
2.39
4.25
0.21
0.06
0.0
17.08
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Privia Health Group, Inc.
Privia Health Group, Inc.
Buy
$2.1B
-50.07%
147.67
0.88%
Solventum Corp
Solventum Corp
Hold
$10.8B
-2.66%
NA
15.73%
Doximity, Inc.
Doximity, Inc.
Hold
$8.1B
-18.17%
54.36
32.53%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$33.6B
32.81%
54.69
23.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$41.6B
48.59%
26.31
8.1%

Insights on Privia Health Group, Inc.

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 415.24M → 422.32M (in $), with an average increase of 1.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 2.83M → 3.46M (in $), with an average increase of 9.4% per quarter

  • Vs DOCS

    In the last 1 year, Doximity, Inc. has given 104.2% return, outperforming this stock by 127.2%

Institutional Holdings

  • FMR Inc

    14.97%

  • BlackRock Inc

    14.45%

  • Vanguard Group Inc

    9.98%

  • Durable Capital Partners LP

    7.60%

  • Wellington Management Company LLP

    4.55%

  • T. Rowe Price Investment Management,Inc.

    4.48%

Company Information

we believe this is the most exciting time in history to be involved in healthcare. our team is leading transformative change; rapidly evolving the system from “sick care” to “well care.” we think life’s too short not to do something with passion, and here at privia we’re doing something that makes a tangible difference. we look for people with that passion. people who want to experience life to the fullest. people who are curious, resourceful, hard working, and tenacious. people who disdain the status quo. our culture is made up of people who look at the world and see opportunity, and who aren’t afraid to dive right in, experience life, and make that opportunity happen.

Organization
Privia Health Group, Inc.
Employees
1102
CEO
Mr. Parth Mehrotra
Industry
Healthcare

Discover More

FAQs